Breaking News

Repligen Expands Facility

By Gil Roth | November 1, 2013

Waltham boost doubles chromatography capacity

Repligen Corp. has completed a 9,000-sq.-ft. expansion of its manufacturing facilities at its Waltham, MA headquarters to meet growth in demand for its bioprocessing products and to ensure that the quality, capacity and support needs of its customers continue to be met.

A dedicated production suite more than doubles capacity for the Company's OPUS line of pre-packed chromatography columns, with cleanrooms built to ISO 7 specifications providing an appropriately controlled environment to satisfy the GMP standards of the company's biopharma customers.

"This expansion will enable us to meet the critical needs of our customers for quality and timely delivery," said Walter C. Herlihy, Ph.D., president and chief executive officer of Repligen. "The new cleanroom suite enables us to produce OPUS columns under the highest quality standard demanded by biopharmaceutical manufacturers."

The facility expansion also triples warehouse space and includes dedicated purification and fermentation laboratories for optimization of existing manufacturing processes, new product development and applications support. An additional 17,000 sq. ft. is reserved for future expansion of the same facility.
blog comments powered by Disqus
  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • What is Driving the Outsourcing Market?

    What is Driving the Outsourcing Market?

    Divyaa Ravishankar, Senior Industry Analyst, Frost & Sullivan Life Sciences||January 29, 2015
    CRO industry generates healthy partnerships through co-development of drugs, diagnostics and demand for functional services.